HBP-assay
Commercial- Indications
- Sepsis
Company intelligence / Profile preview
Axis-Shield Diagnostics develops and manufactures innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care. Their products include proprietary markers for critical illnesses such as cardiovascular and neurodegenerative diseases, rheumatoid arthritis, diabetes monitoring, sepsis risk stratification, syphilis screening, and cell isolation reagents. The company’s commercialized product lines include the Afinion™ system for point-of-care testing and density gradient media widely used in research labs worldwide. They have established OEM agreements with major global platform suppliers such as Abbott.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axis-Shield Diagnostics.